New Drug for Dialysis-related Itching

Itching is a form of pain, and dialysis-related itching affects up to 40% of people on dialysis—with no approved treatment. Vifor Pharma and Cara Therapeutics have signed a licensing agreement to bring Korsuva (difelikefalin) injections to the market.

Read the full article » | Posted 11-12-2020

Related Articles

• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
• Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026
• HollyTM Implantable Continuous Dialysis System Could be Ready for Human Trials Soon Posted 04-14-2026